Medical device developer Jeffrey Greiner is the former CEO of Advanced Bionics, a firm which manufactures and sells cochlear implants, and is now part of Sonova, the Swiss hearing aid giant. Jeff Greiner is enthusiastic about combining the hearing aid advances of Sonova’s Phonak products along with the sophisticated signal processing of Advanced Bionics’ present technology.
Advanced Bionics’ cochlear implants now incorporate some of the most state-of-the-art technology available in the field, including the exclusive Phonak Binaural VoiceStream Technology™ and ClearVoice™, which allow implant recipients to isolate and hear speech better in noisy situations. Binaural VoiceStream Technology allows people with hearing impairments to negotiate particularly challenging situations, permitting them to hear speech on especially windy days and in noisy crowds. It enables them to focus either automatically or manually on the clearest speech source in these environments and provides more signal and thus better understanding.
The technology also gives more and better high frequency audibility and reduces feedback, reverberation and echoes. Finally, Phonak technology adaptively increases sound amplification levels in order to let new users acclimate themselves gradually to their new hearing implants until their pre-determined target is reached.